148 related articles for article (PubMed ID: 29614416)
1. Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
Kang S; Lee JM; Jeon B; Elkamhawy A; Paik S; Hong J; Oh SJ; Paek SH; Lee CJ; Hassan AHE; Kang SS; Roh EJ
Eur J Med Chem; 2018 May; 151():186-198. PubMed ID: 29614416
[TBL] [Abstract][Full Text] [Related]
2. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
Kang S; Hong J; Lee JM; Moon HE; Jeon B; Choi J; Yoon NA; Paek SH; Roh EJ; Lee CJ; Kang SS
Mol Cancer Ther; 2017 Jan; 16(1):217-227. PubMed ID: 28062709
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux.
Xia Y; Xu F; Xiong M; Yang H; Lin W; Xie Y; Xi H; Xue Q; Ye T; Yu L
Pharmacol Res; 2021 Jan; 163():105295. PubMed ID: 33176207
[TBL] [Abstract][Full Text] [Related]
4. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.
Bhat K; Saki M; Vlashi E; Cheng F; Duhachek-Muggy S; Alli C; Yu G; Medina P; He L; Damoiseaux R; Pellegrini M; Zemke NR; Nghiemphu PL; Cloughesy TF; Liau LM; Kornblum HI; Pajonk F
Proc Natl Acad Sci U S A; 2020 May; 117(20):11085-11096. PubMed ID: 32358191
[TBL] [Abstract][Full Text] [Related]
5. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect.
Karpel-Massler G; Kast RE; Westhoff MA; Dwucet A; Welscher N; Nonnenmacher L; Hlavac M; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
J Neurooncol; 2015 Mar; 122(1):21-33. PubMed ID: 25524815
[TBL] [Abstract][Full Text] [Related]
7. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
8. Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.
Zhang X; Xu R; Zhang C; Xu Y; Han M; Huang B; Chen A; Qiu C; Thorsen F; Prestegarden L; Bjerkvig R; Wang J; Li X
J Exp Clin Cancer Res; 2017 Sep; 36(1):118. PubMed ID: 28870216
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
[TBL] [Abstract][Full Text] [Related]
10. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
[TBL] [Abstract][Full Text] [Related]
11. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
12. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
[TBL] [Abstract][Full Text] [Related]
13. A novel technique of serial biopsy in mouse brain tumour models.
Rogers S; Hii H; Huang J; Ancliffe M; Gottardo NG; Dallas P; Lee S; Endersby R
PLoS One; 2017; 12(4):e0175169. PubMed ID: 28394918
[TBL] [Abstract][Full Text] [Related]
14. How reliable are in vitro IC
Damiani E; Solorio JA; Doyle AP; Wallace HM
Toxicol Lett; 2019 Mar; 302():28-34. PubMed ID: 30562549
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.
Laramy JK; Kim M; Gupta SK; Parrish KE; Zhang S; Bakken KK; Carlson BL; Mladek AC; Ma DJ; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2017 Nov; 363(2):136-147. PubMed ID: 28847917
[TBL] [Abstract][Full Text] [Related]
16. Against Repurposing Methadone for Glioblastoma Therapy.
Vatter T; Klumpp L; Ganser K; Stransky N; Zips D; Eckert F; Huber SM
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560384
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
18. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
Narla RK; Liu XP; Myers DE; Uckun FM
Clin Cancer Res; 1998 Jun; 4(6):1405-14. PubMed ID: 9626456
[TBL] [Abstract][Full Text] [Related]
19. Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.
Stringer BW; De Silva MI; Greenberg Z; Noreña Puerta A; Adams R; Milky B; Zabolocki M; van den Hurk M; Ebert LM; Fairly Bishop C; Conn SJ; Kichenadasse G; Michael MZ; Ormsby RJ; Poonoose S; Bardy C
Sci Adv; 2023 Oct; 9(43):eadf1332. PubMed ID: 37878712
[TBL] [Abstract][Full Text] [Related]
20. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
